Reportlinker Adds Therapeutics for Memory and Cognition Disord...(MPONENT SYSTEMS 11 Working Memory 11 ...),Health

Working Memory 11

Knowledge Base (Long-term Memory) 11

Executive System 12

Response System 12

COMPONENT PROCESSES 13

Attention 13

Perception 13

Memory and Learning 13

Organization 13

Reasoning and Problem Solving 14

COGNITION VERSUS MEMORY 14

HOW ARE COGNITION AND MEMORY MEASURED? 15

TABLE 1 DIAGNOSTIC TESTS 15

TABLE 1 (CONTINUED) 16

THE CHALLENGE 17

MAIN DISEASE AREAS 18

MARKET SIZE AND KEY PLAYERS 18

TABLE 2 TOP COMPANIES WORKING IN MEMORY AND COGNITION AND ASSOCIATED WORLDWIDE MARKET SHARE (%) 19

HISTORY 19

FUTURE DEVELOPMENT 19

Chapter-3: APPLICATIONS

PRIMARY 20

TABLE 3 DEMENTIA RATE BY UNDERLYING DISEASE STATE (%) 20

FIGURE 1 DEMENTIA CASES BY UNDERLYING DISEASE STATE (%) 21

SECONDARY 22

MEDICATION-RELATED 22

SUBSTANCE ABUSE 23

CREUTZFELDT JAKOB DISEASE 23

Creutzfeldt Jakob Disease (Continued) 24

ADHD 25

MULTIPLE SCLEROSIS 25

Multiple Sclerosis (Continued) 26

INFECTION 27

METABOLIC DISORDERS 27

BRAIN TUMORS 28

CABG 28

TABLE 4 PERCENT OF PATIENTS WITH DEMENTIA/COGNITIVE DEFICIT (%) 28

PRIMARY 28

ALZHEIMER'S DISEASE 28

TABLE 5 WORLDWIDE DISEASE PREVALENCE: ALZHEIMER'S DISEASE (%) 29

TABLE 6 EXISTING TREATMENTS: ALZHEIMER'S DISEASE 29

Role of the Cholinergic System 29

Role of Beta-Amyloid Protein 30

TABLE 7 TREATMENT FORECAST FOR ALZHEIMER'S DISEASE, THROUGH 2014 ($ MILLIONS) 31

FIGURE 2 TREATMENT FORECAST FOR ALZHEIMER'S DISEASE, 2007-2014 ($ MILLIONS) 31

VASCULAR DEMENTIA 32

TABLE 8 WORLDWIDE DISEASE PREVALENCE: VASCULAR DEMENTIA (%) 32

TABLE 9 EXISTING TREATMENTS: VASCULAR DEMENTIA 32

Cause 33

VCIND 34'/>"/>